223 related articles for article (PubMed ID: 14965231)
1. Schizophrenia: from dopamine to glutamate and back.
Carlsson ML; Carlsson A; Nilsson M
Curr Med Chem; 2004 Feb; 11(3):267-77. PubMed ID: 14965231
[TBL] [Abstract][Full Text] [Related]
2. Partial agonism and schizophrenia.
Bolonna AA; Kerwin RW
Br J Psychiatry; 2005 Jan; 186():7-10. PubMed ID: 15630117
[No Abstract] [Full Text] [Related]
3. Dopamine partial agonists: a new class of antipsychotic.
Lieberman JA
CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole as a dopamine partial agonist: positive and negative effects.
Glick ID; Duggal V; Hodulik C
J Clin Psychopharmacol; 2006 Feb; 26(1):101-3. PubMed ID: 16415723
[No Abstract] [Full Text] [Related]
5. Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1165-78. PubMed ID: 21087552
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
[TBL] [Abstract][Full Text] [Related]
7. Partial agonists in schizophrenia.
Cousins DA; Young AH
Br J Psychiatry; 2005 Apr; 186():354. PubMed ID: 15802697
[No Abstract] [Full Text] [Related]
8. In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
Jordan S; Regardie K; Johnson JL; Chen R; Kambayashi J; McQuade R; Kitagawa H; Tadori Y; Kikuchi T
J Psychopharmacol; 2007 Aug; 21(6):620-7. PubMed ID: 17092971
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
Tsai SJ
Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
[TBL] [Abstract][Full Text] [Related]
10. The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics.
Mizrahi R; Mamo D; Rusjan P; Graff A; Houle S; Kapur S
Int J Neuropsychopharmacol; 2009 Jun; 12(5):715-21. PubMed ID: 19366489
[TBL] [Abstract][Full Text] [Related]
11. Do dopamine partial agonists have partial efficacy as antipsychotics?
Stahl SM
CNS Spectr; 2008 Apr; 13(4):279-82. PubMed ID: 18408646
[No Abstract] [Full Text] [Related]
12. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.
Burke MJ; Lincoln J
Ann Clin Psychiatry; 2006; 18(2):129-30. PubMed ID: 16754419
[No Abstract] [Full Text] [Related]
13. [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].
Costentin J
Ann Pharm Fr; 2009 Sep; 67(5):310-9. PubMed ID: 19695367
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
Hirose T; Kikuchi T
J Med Invest; 2005 Nov; 52 Suppl():284-90. PubMed ID: 16366516
[TBL] [Abstract][Full Text] [Related]
15. [Aripiprazole as "dopamine sensitivity stabilizer"].
Tadokoro S
Nihon Rinsho; 2013 Apr; 71(4):684-8. PubMed ID: 23678600
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole (Otsuka Pharmaceutical Co).
Ozdemir V; Fourie J; Ozdener F
Curr Opin Investig Drugs; 2002 Jan; 3(1):113-20. PubMed ID: 12054061
[TBL] [Abstract][Full Text] [Related]
17. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.
Tamminga CA; Carlsson A
Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):141-7. PubMed ID: 12769623
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
Paulzen M; Gründer G
Int J Neuropsychopharmacol; 2007 Feb; 10(1):149-51. PubMed ID: 16942633
[No Abstract] [Full Text] [Related]
19. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
Crismon ML; DeLeon A; Miller AL
Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
[No Abstract] [Full Text] [Related]
20. [A new atypical antipsychotic with partial dopamine agonist effect (aripiprazole)].
Kerpel-Fronius S; Lóránt M
Neuropsychopharmacol Hung; 2004 Dec; 6(4):177-84. PubMed ID: 15825673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
